CDE News and Press, Coeur Mining Inc. From 05/01/24

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

2024-04-30 14:33:44 ET More on Materials Sector XLB Surges To The Sector-Performance Lead, More Upside Likely 10 Materials stocks that beat Q1 earnings estimates this week Albemarle remains the most heavily shorted materials stock in March Seeking Alphaȁ...

2024-04-30 12:06:00 ET More on Coeur Mining Coeur Mining: Limited Margin Of Safety At Current Levels Coeur Mining, Inc. 2023 Q4 - Results - Earnings Call Presentation Coeur Mining, Inc. (CDE) Q4 2023 Earnings Call Transcript Coeur Mining achieves commercial p...

2024-04-29 10:30:03 ET Cantor Fitzgerald analyst issues HOLD recommendation for CDE on April 29, 2024 08:53AM ET. CDE was trading at $4.79 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy recommend...

2024-04-29 10:00:08 ET Mike Kozak from Cantor Fitzgerald issued a price target of $5.00 for CDE on 2024-04-29 08:53:00. The adjusted price target was set to $5.00. At the time of the announcement, CDE was trading at $4.79. The overall price target consensus is at $4.41 w...

2024-04-24 12:44:16 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips You don’t need much to understand the incentive for gold stocks to buy. Just open a newspaper (or a news app for the modern audience). First and foremost, ongoing geopolitical flashp...

Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today published its 2023 ESG Report (the “Report”), highlighting the Company’s efforts to advance its environmental, social and governance strategy, priorities and practices and its responsi...

2024-04-22 08:23:50 ET More on pre-market losers & stocks. Bio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcript Bio-Path announces $1.2M registered direct offering priced at-the-market Bio-Path shares rally after clinical trial progress of BP1002 ...

2024-04-19 15:30:02 ET National Bank analyst issues OUTPERFORM recommendation for CDE on April 19, 2024 01:26PM ET. The previous analyst recommendation was Outperform. CDE was trading at $4.465 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-04-18 14:15:00 ET Summary Don Durrett talks gold and silver miners' 3.5 year correction. Gold and silver have both surpassed their breakout levels, with silver at $28 being an important level to watch. HUI Gold Index and the risk-on trade on Wall Street are two important ...